Kyowa Kirin Co., Ltd. (TYO:4151)
Japan · Delayed Price · Currency is JPY 2,394.00
+32.00 (1.35%)
May 1, 2026, 3:30 PM JST
Kyowa Kirin Market Cap
Kyowa Kirin has a market cap or net worth of 1.25 trillion as of May 5, 2026. Its market cap has increased by 15.51% in one year.
Market Cap
1.25T
Enterprise Value
1.03T
Revenue
496.83B
Ranking
n/a
PE Ratio
18.69
Stock Price
2,394.00
Market Cap Chart
Since May 6, 1994, Kyowa Kirin's market cap has increased from 435.63B to 1.25T, an increase of 187.68%. That is a compound annual growth rate of 3.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 1.25T | -5.26% |
| Dec 30, 2025 | 1.32T | 9.41% |
| Dec 30, 2024 | 1.21T | -5.11% |
| Dec 29, 2023 | 1.27T | -21.50% |
| Dec 30, 2022 | 1.62T | -3.64% |
| Dec 30, 2021 | 1.68T | 11.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 13.57T |
| Otsuka Holdings | 5.91T |
| Daiichi Sankyo Company | 4.80T |
| Astellas Pharma | 3.95T |
| Ono Pharmaceutical | 1.09T |
| Santen Pharmaceutical | 528.52B |
| JCR Pharmaceuticals | 66.24B |
| Perseus Proteomics | 3.24B |